Quentin McCubbin
Geen lopende functies
Vermogen: 39 347 $ op 31-05-2024
Loopbaan van Quentin McCubbin
Eerdere bekende functies van Quentin McCubbin
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Cerevel Therapeutics LLC
Cerevel Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cerevel Therapeutics LLC operates as a biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system. The company was founded in 2018 and is headquartered in Boston, MA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2019 | 01-01-2021 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01-08-2012 | 01-01-2019 |
KORRO BIO, INC. | Corporate Officer/Principal | 19-01-2021 | - |
Opleiding van Quentin McCubbin
Monash University | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 3 |
Australië | 2 |
Japan | 2 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Frequency Therapeutics, Inc.
Frequency Therapeutics, Inc. BiotechnologyHealth Technology Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the business of developing therapeutics to activate a person's innate regenerative potential to restore function. The firm is also involved in creating and commercializing therapeutics to potentially transform the lives of individuals by repairing or reversing damage done to cells, tissue, and organs. The company was founded by Robert S. Langer, David L. Lucchino, Christopher R. Loosey, and Will J. McLean on November 13, 2014 and is headquartered in Lexington, MA. | Health Technology |
Cerevel Therapeutics LLC
Cerevel Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cerevel Therapeutics LLC operates as a biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system. The company was founded in 2018 and is headquartered in Boston, MA. | Health Technology |
- Beurs
- Insiders
- Quentin McCubbin
- Ervaring